Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura

Muscle Nerve. 2008 Aug;38(2):1076-7. doi: 10.1002/mus.21073.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Action Potentials / radiation effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Electric Stimulation / methods
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Neural Conduction / drug effects
  • Neural Conduction / physiology
  • Neural Conduction / radiation effects
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / complications
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / complications
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Retrospective Studies
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab